Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. (Lantheus) is a global leader in diagnostic imaging is engaged in developing and marketing imaging products for nuclear and ultrasound cardiovascular diagnostic imaging procedures. Its product portfolio includes Cardiolite (kit for the preparation of technetium Tc99m sestamibi for injection), DEFINITY Vial for (perflutren lipid microsphere) injectable suspension, TechneLite (technetium Tc99m generator) and NEUROLITE (kit for the preparation of technetium Tc99m bicisate for injection) used to illuminate the heart and other organs. The company operates in the US, Puerto Rico, Canada, and Australia. Lantheus is headquartered in Massachusetts, the US.